The requirements to clinicopathology about targeted therapy for breast cancer.
- Author:
Ze-fei JIANG
;
Ge SHEN
- Publication Type:Editorial
- MeSH:
Antibodies, Monoclonal;
therapeutic use;
Antibodies, Monoclonal, Humanized;
Antineoplastic Agents;
therapeutic use;
Antineoplastic Combined Chemotherapy Protocols;
therapeutic use;
Breast Neoplasms;
drug therapy;
metabolism;
pathology;
Carcinoma, Ductal, Breast;
drug therapy;
metabolism;
pathology;
Female;
Humans;
Receptor, ErbB-2;
metabolism;
Trastuzumab
- From:
Chinese Journal of Pathology
2007;36(7):435-437
- CountryChina
- Language:Chinese
